¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sickle cell disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • secondary disease
    ¼Ó¹ßº´, ¼Ó¹ßÁúȯ
  • self-limited disease
    ÀڱⱹÇѺ´
  • septic disease
    ÆÐÇ÷º´
  • severe combined immunodeficiency disease
    ÁßÁõº¹Çո鿪°áÇ̺´
  • sexually transmitted disease
    ¼º¸Å°³º´, ¼ºº´
  • Sandhoff¡¯s disease
    ÀÜÆ®È£ÇÁº´
  • silo filler¡¯s disease
    »çÀϷγóºÎº´, ¸¶ÃÊÀúÀå°í³óºÎº´
  • Simmonds¡¯ disease
    ½Ã¸ÕÁ
  • sleeping disease
    ¼ö¸éº´
  • Takayasu¡¯s disease
    ´ÙÄ«¾ß½ºº´
  • Tangier disease
    źÁö¿¡¸£º´
  • Unverricht¡¯s disease
    ¿îº£¸®È÷Æ®º´
  • upper motor neuron disease
    À§¿îµ¿½Å°æ¼¼Æ÷º´, »óÀ§¿îµ¿½Å°æ¿øº´
  • upper respiratory disease
    »ó±âµµº´
  • vascular disease
    Ç÷°üº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • acantholytic cell
    °¡½Ã¼¼Æ÷ÇØ¸®¼¼Æ÷
  • accessory cell
    º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
  • acidophilic cell
    È£»ê¼º¼¼Æ÷
  • acinar cell
    »ù²Ê¸®¼¼Æ÷
  • acinic cell carcinoma
    »ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
  • amacrine cell
    ¹«Ãà»è¼¼Æ÷
  • ameboid cell
    ¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
  • annular elastotic giant cell granuloma
    °í¸®Åº·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾, ȯ»óź·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾
  • antibody-dependent cell-mediated cytotoxicity
    Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
  • antibody-producing cell
    Ç×ü»ý»ê¼¼Æ÷
  • antibody-screening cell
    Ç×ü¼±º°Ç÷±¸
  • antigen-presenting cell
    Ç׿øÀü´Þ¼¼Æ÷
  • antigen-reactive cell
    Ç׿ø¹ÝÀÀ¼¼Æ÷
  • antigen-recognizing cell
    Ç׿øÀÎÁö¼¼Æ÷
  • argentaffin cell
    ģũ·ÒÀº¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • persensitized cell
    °ú°¨ÀÛ¼¼Æ÷(ΦÊïíÂá¬øà)
  • petrous tip cell
    Ãßü÷ºÀ¼Ò.
  • photochemical cell
    ±¤È­ÇÐÀüÁö(ÎÃûùùÊ ï³ò®).
  • photoconductive cell
    ±¤Àüµµ¼ÒÀÚ(¡­áÈí­).
  • photoelectric cell
    ±¤ÀüÁö(ÎÃï³ò®).
  • physaliphorous cell
    ´ã°øÆ÷¼¼Æ÷(Ó½Íöøàá¬øà)
  • pigment cell
    »ö¼Ò¼¼Æ÷(ßäáÈá¬øà).
  • pigment cell
    »ö¼Ò¼¼Æ÷
  • pigment cell nevus
    »ö¼Ò¼¼Æ÷¸ð¹Ý
  • pigment cell nevus
    »ö¼Ò¼¼Æ÷¸ð¹Ý(ßäáÈá¬øàÙ½Úè)
  • pigment epithelial cell
    »ö¼Ò»óÇǼ¼Æ÷
  • pigmented basal cell carcinoma
    »ö¼ÒÄ§Âø ±âÀú¼¼Æ÷¾Ï
  • pillar cell
    ÁÖ¼¼Æ÷(ñºá¬øà).
  • pilomotor cell
    ¸ð¹ß¿îµ¿¼¼Æ÷(¡­ê¡ÔÑá¬øà).
  • pinealocyte [clear cell]
    ¼Û°úü¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • disease, Lyme
    ¶óÀÓÁúȯ
  • disease, M ni res
    ¸Þ´Ï¿¡¸£º´
  • disease, Thornwaldts
    Àεγ¶¿°
  • disease, allergic
    ¾Ë·¹¸£±â(¼º) Áúȯ
  • disease, autoimmune inner ear
    ÀÚ°¡¸é¿ª¼º ³»ÀÌÁúȯ
  • disease, gastroesophageal reflux
    À§½Äµµ ¿ª·ù(¼º)Áúȯ
  • disease, marble bone
    ´ë¸®¼® °ñÁúȯ
  • disease, pulseless
    ¹«¸Æ¹ÚÁúȯ
  • disease, sexually transmitted(-misible)
    ¼ºÇàÀ§Àü¿°º´, ¼ºÀμºÁúȯ, ¼ºº´
  • double vessel disease
    ÀÌÇ÷°üÁúȯ.
  • double vessel disease
    ÀÌÁß°ü»óµ¿¸ÆÁúȯ.
  • duncans disease
    ´øÄ­º´
  • duncans disease
    ´øÄ­ º´
  • dust disease
    ¸ÕÁöº´(ÊÙËÓ).
  • dyskeratosis follicularis = Dariers disease
    ¸ð³¶¼º À̰¢È­Á¾
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
IBD inflammatory bowel disease; irritable bowel disease
IPD idiopathic Parkinson disease; idiopathic protracted diarrhea; immediate pigment darkening; increase ...
KD cathodal duration; Kawasaki disease; Kennedy disease; killed
MBD Marchiafava-Bignami disease; Mental Deterioration Battery; methylene blue dye; minimal brain damage;...
MDV Marek disease virus; mean dye [bolus] velocity; mucosal disease virus
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
CHD Congenital Heart Disease
CERAD Consortium To Establish a Registry for Alzheimer's Disease
CAD Coronary Artery Disease
CHD Coronary Heart Disease
CD Cowden Disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • whipple's disease Èí¼öºÎÀü ÁõÈıºÀ¸·Î ¼³»ç, Áö¹æ º¯Áõ, ÇǺλö¼Ò Ä§Âø, °üÀý¿°, °üÀýÅë, ¸²ÇÁÀý¿°, ÁßÃ߽Űæ°èÀå¾Ö°¡ Ư¡ÀÌ´Ù.

    Whipple's triad

    ÇÇÇþ¾ »ï¡ÈÄ
    ¿øÀο¡ °ü°è¾øÀÌ ¸ðµç ÀúÇ÷´çÁõÀÇ Æ¯Â¡À¸·Î 1
  • white finger disease
    ¹é¶øº´
    ¾ÐÃà°ø±â, ÇØ¸Ó, Àüµ¿ Åé µî ¼Õ¿¡ Áã°í Á¶ÀÛÇÏ´Â Áøµ¿°ø±¸ÀÇ Áøµ¿À¸·Î ¼ÕÀÇ µ¿¸ÆÀÌ Àå¾Ö¸¦ ¹Þ¾Æ °©Àڱ⠼հ¡¶ôÀÌ Ã¢¹éÇØÁö´Â º´. »çÁö ¸»´Ü, ƯÈ÷ ¼öÁöÀÇ Ç÷°üÀå¾Ö·Î ÁßÁõÀÏ ¶§´Â ȯºÎ°¡ ±«»ç¿¡ ºüÁö´Â Á÷¾÷º´À¸·Î ·¹À̳ë ÁõÈıºÀÇ ÇÑ º´ÇüÀ¸·Î °£ÁÖÇϰí ÀÖ´Ù. ¿øÀÎÀº Ç÷°ü ¿îµ¿ ½Å°æ Àå¾Ö·Î ÀÎÇÑ µ¿¸Æ ¼öÃà ¶§¹®¿¡ ÀϾ´Â Ç÷·ù Àå¾ÖÀÌ´Ù. Áõ¼¼´Â ¹ßÀÛÀûÀ¸·Î ÀϾ ¼Õ°¡¶ôÀÌ Ã¢¹éÇØÁö¸ç, ÅëÁõ°ú Àú¸®´Â °¨ÀÌ ÀÖ°í, ÀÌ¾î º¸¶ó»öÀ¸·Î º¯Çß´Ù°¡ ºÓ¾îÁö¸é¼­ ȸº¹µÇ¸ç, ÀÌ »çÀÌ´Â ¼öºÐ ³»Áö ¼ö ½Ê ºÐÀ̰í Ãß¿ï ¶§ ¸¹´Ù. Ä¡·á´Â Ç÷°üÈ®ÀåÁ¦¸¦ »ç¿ëÇÏ°í ¼ÕÀ» Â÷Áö ¾Ê°Ô º¸¿Â¿¡ ÁÖÀÇÇϸç, °ø±¸ »ç¿ëÀº ÀÏÁ¤ ±â°£ »ï°¡´Â °ÍÀÌ ÁÁ´Ù.
  • woolsorters disease
    ¾ç¸ð¾÷ÀÚº´
    ¾ç¸ð¸¦ Ãë±ÞÇÏ´Â »ç¶÷¿¡¼­ º¼ ¼ö ÀÖ´Â ÆóÀÇ ÅºÀú·Î, B. anthrax¸¦ ÈíÀÔÇÔÀ¸·Î½á ÀϾ´Ù.
  • Zahorsky's disease
    ÀÚÈ£¸£½ºÅ° º´
    À¯¾Æ¿¡¼­ º¼ ¼ö ÀÖ´Â µ¹¹ß¼º ¹ßÁø.
  • Ziehen-Oppengeim disease
    Á¦¿£-¿ÀÆæÇÏÀÓº´
  • Abbe-Zeiss counting cell
    ¾Ðº£-ÀÚÀ̽º Ç÷±¸ °è»ê
  • abnormality of cell interaction
    ¼¼Æ÷ »óÈ£ÀÛ¿ë ÀÌ»ó
    ¼¼Æ÷ »çÀÌ¿¡ ÀϾ´Â ÀÛ¿ëÀÌ ºñÁ¤»óÀûÀÎ °Í.
  • absolute cell increase
    Àý´ë ¼¼Æ÷ ¼ö Áõ°¡
  • absorptive cell
    Èí¼ö ¼¼Æ÷
  • accessory cell
    ºÎ¼¼Æ÷
    °ñÀú¼± Áß¿¡¼­ ÁÖ¼¼Æ÷, ¹æ¼¼Æ÷¿¡ ¼¯¿©¼­ Á¸ÀçÇÑ´Ù. ÀÔ¹æÇüÀ̸ç Á¡¾×¼ºÀÇ ¹°ÁúÀ» °£Á÷ÇÑ´Ù. ÇÙÀº ¼¼Æ÷Àú¿¡ Ä¡¿ìÃÄ ÀÖ¾î ÆíÆò¿¡ °¡±õ´Ù.
  • acinic cell carcinoma
    ¼±¹æ ¼¼Æ÷ ¾ÏÁ¾
    1. ¼±¹æ ¼¼Æ÷, ±Ù»óÇǼ¼Æ÷°¡ Áõ½ÄÇÏ¿© Çü¼ºµÇ°í ³·Àº ¾Ç¼ºµµ¸¦ º¸ÀδÙ. 2. Ÿ¾×¼± ¾à¼º Á¾¾ç Áß 5¹øÂ°ÀÇ ¹ß»ý ºñÀ²À» °®´Â Á¾¾çÀ¸·Î 90%¿¡¼­ ÀÌÇϼ±¿¡¼­ ¹ß»ýÇÏ¸ç ¾ÇÇϼ±°ú ¼ÒŸ¾×¼±¿¡¼­µµ µå¹°°Ô ¹ß»ýÇÑ´Ù. ¿©¼º¿¡¼­ ´Ù¼Ò È£¹ßÇϰí, ¾î´À ¿¬·É¿¡¼­³ª ¹ß»ýÇϳª ÁÖ·Î 30-70´ë¿¡ °ñ°í·ç ¹ß»ýÇÑ´Ù. ¿¹Àü¿¡´Â ¾ç¼ºÀ¸·Î »ý°¢ÇÏ¿© ¼±¹æ¼¼Æ÷Á¾À̶ó ºÎ¸¥ ÀûÀÌ ÀÖÀ¸³ª ºÐ¸íÇÑ ¾Ç¼ºÀ¸·Î ¼±¾ÏÁ¾À¸·Î ºÎ¸¥´Ù. Á¾¾ç ¼¼Æ÷´Â Àå¾×¼º ¼±¹æ¼¼Æ÷¿Í À¯»çÇÏÁö¸¸ ¿©·¯ °¡Áö ´Ù¸¥ ¼¼Æ÷µéÀÌ ³ªÅ¸³ª¸ç, °³Á¦°ü ¿¹ºñ¼¼Æ÷¿¡¼­ ±â¿øÇÑ´Ù°í º»´Ù.
  • adamantinoid basal cell carcinoma
    ¹ý¶û Á¾¾ç ±âÀú¼¼Æ÷¾Ï
  • adenoid basal cell carcinoma
    ¼±»ó ±âÀú¼¼Æ÷¾Ï
  • adenosquamous cell carcinoma
    ¼± ÆíÆò»óÇÇ ¼¼Æ÷¾Ï
    ¼± ¾Ï°ú ÆíÆò¼¼Æ÷ ¾ÏÀÌ È¥ÀçµÇ¾î ÀÖ´Â °Í. ÀÚ±Ã°æ ³»¸· »óÇÇÀÇ ±âÀú Ãþ¿¡ ÀÖ´Â ¿¹ºñ ¼¼Æ÷¿¡¼­ ¹ß»ý. ÀÌ´Â °°Àº º´±âÀÇ ÆíÆò¼¼Æ÷ ¾Ï°ú ºñ±³ÇÏ¿© ¿¹Èİ¡ ´õ ³ª»Ú´Ù.
  • adipose cell
    Áö¹æ ¼¼Æ÷
    Áö¹æÀ» °¡Áø ¼¼Æ÷·Î¼­ ¼¼Æ÷´Â ±¸ÇüÀ» ÀÌ·ç°í, ÇÙÀº ÇÑ ÂÊÀ¸·Î Ä¡¿ìÃÄ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
cell lineage <cell culture, embryology> The lineage of a cell relates to its derivation from the undifferentiated tissues of the embryo.
Committed embryonic progenitors give rise to a range of differentiated cells: in principle it should be possible to trace the ancestry lineage) of any adult cell.
(26 Mar 1998)
cell line rights <cell culture> Ownership of a new organism entity. Rulings indicate that any organism that is patentable at all can be patented if it has been manipulated to do something useful.
Usually, the rights do not reside with the individual who has supplied the source of the organism, but with the individual or organisation who has made it.
(26 Mar 1998)
cell line, transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumour. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals.
(12 Dec 1998)
cell locomotion <cell biology> Movement of a cell from one place to another.
(26 Mar 1998)
cell marker <cell biology> Biochemical or genetic characteristics which distinguish and discriminate between different cell types.
(26 Mar 1998)
cell matrix A fluid cytoplasmic substance filling the interstices of the cytoskeleton.
Synonym: cell matrix, cytomatrix.
(05 Mar 2000)
cell-mediated immunity <immunology> Immune response that involves effector T lymphocytes and not the production of humoral antibody.
Responsible for allograft rejection, delayed hypersensitivity and in defence against viral infection and intracellular protozoan parasites.
(26 Mar 1998)
cell-mediated reaction Immunological reaction of the delayed type, involving chiefly T lymphocytes, important in host defense against infection, in autoimmune diseases, and in transplant rejection.
See: skin test.
(05 Mar 2000)
cell membrane <cell biology> The structure enveloping a cell, enclosing the cytoplasm and forming a selective permeability barrier.
It consists of lipids, proteins and some carbohydrates, the lipids thought to form a bilayer in which integral proteins are embedded to varying degrees.
Synonym: plasma membrane.
(26 Mar 1998)
cell membrane permeability A quality of cell membranes which permits the passage of solvents and solutes into and out of cells.
(12 Dec 1998)
cell migration <cell biology> Implies movement of a population of cells from one place to another as in the movement of neural crest cells during morphogenesis.
(26 Mar 1998)
cell migration inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated leukocytes or macrophages. Specific assays have been developed to estimate levels of migration-inhibitory factor, immune reactivity against tumour-associated antigens, and immunosuppressive effects of infectious microorganisms.
(12 Dec 1998)
cell movement <cell biology> A more general term than locomotion, that can include shape change, cytoplasmic streaming etc.
(26 Mar 1998)
cell nucleolus Within most types of eukaryotic cell nucleus, a distinct region, not delimited by a membrane, in which some species of rrna (RNA, ribosomal) are synthesised and assembled into ribonucleoprotein subunits of ribosomes. In the nucleolus rrna is transcribed from a nucleolar organiser, i.e., a group of tandemly repeated chromosomal genes which encode rrna and which are transcribed by RNA polymerase I.
(12 Dec 1998)
cell nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (cell nucleolus). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the endoplasmic reticulum. A cell may contain more than one nucleus.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á